In addition, our study suggests that 17β-estradiol may be effective in HCC treatment as it can inhibit tumor cell growth and proliferation by activating the NLRP3 inflammasome and the caspase-1-dependent pyroptosis in HCC cells. The gene discussed is NLRP3; the disease is hepatocellular carcinoma.